Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibacterial
Biotech
Destiny goes private to stay afloat after no partner found
Destiny Pharma’s search for a partner to take its infection prevention med into phase 3 has come up short
James Waldron
Jul 15, 2024 4:33am
BiomX acquires fellow bacteria-killing virus company APT
Mar 6, 2024 9:01am
Boehringer rounds up allies to build €40M anti-superbug startup
Jul 6, 2022 6:01am
Stopping DNA 'packet' exchange could halt bacterial resistance
Jun 14, 2022 8:30am
Big Pharma-backed AMR Action Fund picks 1st biotech investments
Apr 4, 2022 10:25am
Summit turns to partnerships for failed C. difficile med
Mar 18, 2022 11:18am
